As the two trials used a common reference fluid ( 0.9 % saline ) and had most trial methods and data collection points harmonised , a comparison of 4 % albumin and 6 % HES ( 130/0 .4 ) on patient-centred outcomes at 28 days in critically ill patients using the individual patient data from the two trials is feasible .